CNBC October 24, 2023
Key Points
– Wearable startup Signos said Tuesday that it closed a $20 million funding round led by Cheyenne Ventures and GV, formerly Google Ventures.
– Signos’ platform uses data from a continuous glucose monitor, or a CGM, which is a small sensor that tracks glucose levels in real time.
– The company is taking a different tactic to help people lose weight as new drugs such as Ozempic and Wegovy see soaring demand.
Weight loss has always been big business, but it’s exploded of late due to surging demand for Ozempic, Wegovy and other new diabetes and obesity drugs.
In the first half of 2023, sales of Ozempic and Wegovy rose by 58% and 363%, respectively. That’s after quarterly...
Today's Sponsors
Today's Sponsor